LivaNova (LIVN) Cash from Operations (2015 - 2026)
LivaNova's (LIVN) quarterly Cash from Operations came in at $66.6 million in Q2 2026, up 5.83% year-over-year from $62.9 million in Q2 2025, and up 337.62% quarter-over-quarter from $15.2 million in Q1 2026.
Analysis
LivaNova (LIVN) Cash from Operations (2015 - 2026) Analysis & Trends
LivaNova has disclosed Cash from Operations across 12 years of filings, most recently posting $66.6 million for Q2 2026.
- In Q2 2026, Cash from Operations rose 5.83% year-over-year to $66.6 million; the TTM figure through Jun 2026 stood at $249.3 million (up 15.08% YoY), while the FY2025 annual figure was $254.3 million, up 38.95% from the prior year.
- Cash from Operations came in at $66.6 million for Q2 2026 at LivaNova, up from $15.2 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $85.1 million in Q3 2025 to a low of -$17.9 million in Q2 2023.
- Average Cash from Operations over 5 years is $36.9 million, with a median of $30.7 million recorded in 2022.
- Year-over-year, Cash from Operations slumped 139.96% in 2022 and jumped 341.71% in 2024.
- Over 5 years, Cash from Operations stood at $18.7 million in 2022, then surged by 188.5% to $54.0 million in 2023, then soared by 45.87% to $78.7 million in 2024, then climbed by 4.69% to $82.4 million in 2025, then decreased by 19.19% to $66.6 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were $66.6 million in Q2 2026, $15.2 million in Q1 2026, and $82.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 367.10 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 66.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.59 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 82.40 Mn |
| Sep 30, 2025 | 85.06 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Mar 31, 2025 | 23.97 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 43.36 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 53.96 Mn |
| Sep 30, 2023 | 18.14 Mn |
| Jun 30, 2023 | -17.94 Mn |
| Mar 31, 2023 | 20.76 Mn |
| Dec 31, 2022 | 18.70 Mn |
| Sep 30, 2022 | 35.64 Mn |
| Jun 30, 2022 | -10.24 Mn |
| Mar 31, 2022 | 25.82 Mn |
| Dec 31, 2021 | 33.48 Mn |
| Sep 30, 2021 | 23.95 Mn |